SOURCE: annual_report_text (1).txt
CHUNK: 714 of 1106
SIZE: 684 characters
PREVIOUS: chunk_0713_annual_report_text (1).txt
NEXT: chunk_0715_annual_report_text (1).txt
------------------------------
nts. On the basis of its internal financial reports and given the Groups primary source 
of risk and profitability, IBA has identified two operating segments: - 
Proton therapy and other accelerators: This segment constitutes the technological basis of the Groups many 
businesses and encompasses development, fabrication, and services associated with medical and industrial 
particle accelerators and proton therapy systems. - 
Dosimetry: This segment includes the activities that offer a full range of innovative high-quality solutions and 
services that maximize efficiency and minimize errors in radiation therapy and medical imaging Quality 
Assurance and calibration procedures.